Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

Events & ConventionsAGC Pharma Chemicals at BOS Manchester 2024
12th November 2024

AGC Pharma Chemicals at BOS Manchester 2024

We are thrilled to announce our participation in BOS (Biotech Outsourcing Strategies) Manchester 2024, November 26-27.   BOS Manchester 2024's scope is primarily development stage CMC outsourcing for both Small Molecules…
Supply ChainAGC Pharma Chemicals Joins the Pharmaceutical Supply Chain Initiative as a Supplier Partner
6th November 2024

AGC Pharma Chemicals Joins the Pharmaceutical Supply Chain Initiative as a Supplier Partner

AGC Pharma Chemicals, a global contract development and manufacturing organization (CDMO) specializing in small-molecule APIs and intermediates, is proud to announce its new partnership with the Pharmaceutical Supply Chain Initiative…
Events & ConventionsAGC Pharma Chemicals at Bio Europe Stockholm 2024
1th November 2024

AGC Pharma Chemicals at Bio Europe Stockholm 2024

We are excited to be attending Bio Europe 2024 in Stockholm from November 4-6. Our team, represented by Business Development Associate Directors Monica Delgado and João Madeira do Ó, will…